Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T13:25:21.807Z.
Calculation as of: 2026-10-06T13:25:21.807Z.
Quote observation: 2026-10-05T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 397c5a59cd83d044dab6d82224f034cfcc72b23d5b6e8de026e21d37d80d55f6
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2022-11-08.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$228.41M
EV/EBITDA Ratio
N/A
TTM Avg
1.40x
3Y Avg
1.40x
5Y Avg
1.40x
Market Cap
$206.61M
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$239.89M
EV/EBITDA Ratio
12.92x
TTM Avg
20.89x
3Y Avg
46.57x
5Y Avg
889.74x
Market Cap
$244.25M
EV/EBITDA Ratio
N/A
TTM Avg
21.13x
3Y Avg
83.14x
5Y Avg
83.14x
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alector, Inc. (ALEC) | $220.94M | N/A | N/A | N/A | N/A |
| Compugen Ltd. (CGEN)vs › | $218.42M | N/A | 6.24x | 9.83x | 9.83x |
| Keros Therapeutics, Inc. (KROS)vs › | $228.41M | N/A | 1.40x | 1.40x | 1.40x |
| Electra Therapeutics Inc. (ETRA)vs › | $206.61M | N/A | N/A | N/A | N/A |
| Biodesix, Inc. (BDSX)vs › | $236.56M | N/A | N/A | N/A | N/A |
| BioAge Labs Inc. (BIOA)vs › | $239.45M | N/A | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $202.05M | N/A | N/A | N/A | N/A |
| High Tide Inc. (HITI)vs › | $239.89M | 12.92x | 20.89x | 46.57x | 889.74x |
| Akebia Therapeutics, Inc. (AKBA)vs › | $244.25M | N/A | 21.13x | 83.14x | 83.14x |
| Lifecore Biomedical, Inc. (LFCR)vs › | $244.56M | N/A | 28.93x | 31.09x | 27.66x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2022-11-08 | 13.81x |
| 2022-11-07 | 13.52x |
| 2022-11-04 | 13.23x |
| 2022-11-03 | 13.87x |
| 2022-11-02 | 14.68x |
| 2022-11-01 | 15.21x |
| 2022-10-31 | 15.03x |
| 2022-10-28 | 15.66x |
| 2022-10-27 | 14.58x |
| 2022-10-26 | 14.85x |
| 2022-10-25 | 14.70x |
| 2022-10-24 | 14.13x |
| 2022-10-21 | 14.40x |
| 2022-10-20 | 14.15x |
| 2022-10-19 | 14.44x |
| 2022-10-18 | 15.03x |
| 2022-10-17 | 15.24x |
| 2022-10-14 | 13.74x |
| 2022-10-13 | 14.46x |
| 2022-10-12 | 14.40x |
| 2022-10-11 | 14.62x |
| 2022-10-10 | 13.87x |
| 2022-10-07 | 14.01x |
| 2022-10-06 | 14.89x |
| 2022-10-05 | 15.11x |
| 2022-10-04 | 15.72x |
| 2022-10-03 | 15.26x |
| 2022-09-30 | 15.54x |
| 2022-09-29 | 15.52x |
| 2022-09-28 | 15.60x |
| 2022-09-27 | 13.64x |
| 2022-09-26 | 13.05x |
| 2022-09-23 | 13.52x |
| 2022-09-22 | 14.23x |
| 2022-09-21 | 14.48x |
| 2022-09-20 | 15.17x |
| 2022-09-19 | 15.36x |
| 2022-09-16 | 15.09x |
| 2022-09-15 | 16.23x |
| 2022-09-14 | 15.97x |
| 2022-09-13 | 15.11x |
| 2022-09-12 | 16.93x |
| 2022-09-09 | 15.86x |
| 2022-09-08 | 18.54x |
| 2022-09-07 | 18.01x |
| 2022-09-06 | 16.40x |
| 2022-09-02 | 17.50x |
| 2022-09-01 | 18.11x |
| 2022-08-31 | 17.28x |
| 2022-08-30 | 17.77x |
| 2022-08-29 | 17.79x |
| 2022-08-26 | 18.21x |
| 2022-08-25 | 19.64x |
| 2022-08-24 | 19.60x |
| 2022-08-23 | 19.40x |
| 2022-08-22 | 19.17x |
| 2022-08-19 | 19.75x |
| 2022-08-18 | 20.28x |
| 2022-08-17 | 20.19x |
| 2022-08-16 | 21.05x |
| 2022-08-15 | 22.26x |
| 2022-08-12 | 22.87x |
| 2022-08-11 | 21.81x |
| 2022-08-10 | 22.48x |
| 2022-08-09 | 21.81x |
| 2022-08-08 | 22.71x |
| 2022-08-05 | 22.60x |
